# Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee

> **NCT00139295** · PHASE3 · COMPLETED · sponsor: **Genzyme, a Sanofi Company**

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DEVICE:** Hylastan

## Key facts

- **NCT ID:** NCT00139295
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** — (—)
- **Last updated:** 2014-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00139295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00139295, "Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00139295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*